Four COVID vaccine doses superior to three in patients with autoimmune rheumatic disease
Patients with autoimmune rheumatic disease who receive a fourth dose of the Pfizer mRNA COVID-19 vaccine appear to be better protected than patients who receive three doses, according to data published in Rheumatology. “Currently, there are six SARS-CoV-2 vaccines commercially approved globally, and all are highly effective in preventing symptomatic COVID-19 infection, complications, and
Source: healio.com